Company Overview - Ocugen Inc. is a clinical-stage biotechnology company focused on developing modifier gene therapies for rare inherited retinal diseases that lead to progressive vision loss [1]. Pipeline and Focus - The company is particularly concentrating on therapies for diseases that cause vision impairment, indicating a specialized approach within the biotechnology sector [1].